Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?-Reference-Cited by-同舟云学术

Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?

Published:2012-12-10 Issue:35 Volume:30 Page:4294-4296
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Carter H. Ballentine¹,Partin Alan W.¹,Walsh Patrick C.¹,Trock Bruce J.¹,Veltri Robert W.¹,Nelson William G.¹,Coffey Donald S.¹,Singer Eric A.²,Epstein Jonathan I.¹

Affiliation:

1. The Johns Hopkins University and Johns Hopkins Hospital, Baltimore, MD

2. National Cancer Institute, National Institutes of Health, Bethesda, MD

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.44.0586

Reference30 articles.

1. National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer

2. SHOULD WE REALLY CONSIDER GLEASON 6 PROSTATE CANCER?

3. Call It Cancer

4. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

5. Gleason Score 2–4 Adenocarcinoma of the Prostate on Needle Biopsy

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is cancer? A focus on Grade Group 1 prostate cancer;BJU International;2024-01-16

2. Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy;The Prostate;2024-01-03

3. Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy;Journal of Urology;2023-12-18

4. Physician Perception of Grade Group 1 Prostate Cancer;European Urology Focus;2023-11

5. Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs;European Urology;2023-11